These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10794753)

  • 1. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays.
    Brossard JH; Lepage R; Cardinal H; Roy L; Rousseau L; Dorais C; D'Amour P
    Clin Chem; 2000 May; 46(5):697-703. PubMed ID: 10794753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
    Messa P; Mioni G; Turrin D; Guerra UP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDIGO CATEGORIES OF GLOMERULAR FILTRATION RATE AND PARATHYROID HORMONE SECRETION IN PRIMARY HYPERPARATHYROIDISM.
    Tassone F; Gianotti L; Baffoni C; Pellegrino M; Castellano E; Borretta G
    Endocr Pract; 2015 Jun; 21(6):629-33. PubMed ID: 25716636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of volume expansion, purified parathyroid extract, and calcium on renal bicarbonate absorption in the dog.
    Crumb CK; Martinez-Maldonado M; Eknoyan G; Suki WN
    J Clin Invest; 1974 Dec; 54(6):1287-94. PubMed ID: 4436433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between "intact" PTH and 1-84 PTH assays in chronic renal failure and dialysis.
    Waller S; Ridout D; Cantor T; Rees L
    Pediatr Nephrol; 2005 Feb; 20(2):197-9. PubMed ID: 15627166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
    Donadio C; Ardini M; Lucchesi A; Donadio E; Cantor T
    Clin Nephrol; 2007 Mar; 67(3):131-9. PubMed ID: 17390737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism.
    Tassone F; Gianotti L; Emmolo I; Ghio M; Borretta G
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4458-61. PubMed ID: 19808852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
    Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
    Herberth J; Fahrleitner-Pammer A; Obermayer-Pietsch B; Krisper P; Holzer H; Malluche HH; Dobnig H
    Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.
    Kurajoh M; Inaba M; Yamada S; Imanishi Y; Tsuchida T; Ishimura E; Nishizawa Y
    Osteoporos Int; 2008 May; 19(5):709-16. PubMed ID: 18239958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between glomerular filtration rate, uric acid, and parathyroid hormone in children].
    Diallo D; Dubourg L; Ranchin B; Cochat P; Bacchetta J
    Arch Pediatr; 2013 Jun; 20(6):601-7. PubMed ID: 23642898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum trypsin-like immunoreactivity and secondary hyperparathyroidism in renal failure.
    Antonucci F; Vezzadini P; Adorati M; Bonora G; Messa P; Montanaro D; Mioni G
    Scand J Gastroenterol Suppl; 1980; 62():53-7. PubMed ID: 6161411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y; Benchetrit S; Golan E; Zitman-Gal T
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
    Kazama JJ; Omori T; Ei I; Ei K; Oda M; Maruyama H; Narita I; Gejyo F; Shigematsu T; Fukagawa M
    Clin Exp Nephrol; 2003 Jun; 7(2):144-9. PubMed ID: 14586733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact parathyroid hormone levels in renal insufficiency.
    Fajtova VT; Sayegh MH; Hickey N; Aliabadi P; Lazarus JM; LeBoff MS
    Calcif Tissue Int; 1995 Nov; 57(5):329-35. PubMed ID: 8564794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.